Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 38 clinical trials
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

, abatacept, and short-duration tacrolimus for GvHD prophylaxis.

carbon monoxide diffusing capacity
fungal infection
tacrolimus
carbon monoxide
abatacept
  • 0 views
  • 16 May, 2022
  • 1 location
Abatacept s.c. for aGVHD Prevention in Haplo-HCT

. Abatacept has been demonstrated as a potent drug to reduce the risk of aGVHD, but the efficacy of subcutaneous form has yet been investigated. This trial is designed to preliminarily determin the efficacy

  • 0 views
  • 10 Jun, 2021
  • 1 location
Effects of Abatacept on Myocarditis in Rheumatoid Arthritis (AMiRA)

This study aims to evaluate the effects of abatacept, a CTLA4-Ig fusion protein that binds CD80/86 (B7-1/B7-2), on subclinical myocarditis in rheumatoid arthritis (RA) through its effect on T

pet/ct scan
abatacept
adalimumab
methotrexate
fusion protein
  • 97 views
  • 21 Feb, 2022
  • 1 location
Abatacept for the Treatment of Giant Cell Arteritis

This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or

  • 0 views
  • 27 Jul, 2022
  • 6 locations
Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis

The aim of this study is to observe the clinical efficacy and safety of abatacept combined with JAK inhibitor in the treatment of D2TRA patients

Accepts healthy volunteers
abatacept
antirheumatics
  • 0 views
  • 22 Jul, 2022
  • 1 location
Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy (ATARI)

This is a phase 2a, multi-center, randomized and double-blind placebo-controlled trial comparing 24 weeks of abatacept versus placebo used as adjuvant to oral immunotherapy to induce remission

  • 0 views
  • 27 May, 2022
  • 1 location
Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease (ABCVILD)

There is no standard of care therapy for patients with granulomatous-lymphocytic interstitial lung disease (GLILD) seen in common variable immunodeficiency (CVID). Abatacept has recently looked

lung biopsy
immunodeficiency
interstitial lung disease
serum igg
immune globulin
  • 8 views
  • 27 May, 2022
  • 1 location
Abatacept in Individuals Who aRe Considered At Risk of Developing Inflammatory Arthritis (ARCADIA)

Phase II, single-centre, open label, two parallel arm cohort randomised controlled trial (RCT) testing abatacept in a population of anti-CCP Ab positive individuals at moderate to high risk of

abatacept
stiffness
  • 74 views
  • 02 Mar, 2022
  • 1 location
Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

This phase II trial studies how well abatacept, ixazomib citrate, and dexamethasone work in treating patients with multiple myeloma that is resistant to chemotherapy. Abatacept may block certain

tumor cells
proteasome inhibitor
bortezomib
platelet count
carfilzomib
  • 6 views
  • 11 May, 2022
  • 3 locations
Abatacept vs Tocilizumab for the Treatment of RA in TNF Alpha Inhibitor Inadequate Responders (SUNSTAR)

. This new biotherapy class includes tocilizumab and abatacept, two drugs recently available for subcutaneous administration that enables ambulatory care for patients who would otherwise require

abatacept
antirheumatics
DMARD
tumor necrosis factor alpha
tumor necrosis factor inhibitors
  • 11 views
  • 13 Feb, 2022
  • 1 location